Commercial-grade preparations of two
thiocarbamate herbicides,
diallate and
triallate, were evaluated for their mutagenic potential in a battery of short-term bioassays. All in vitro bioassays were performed with and without mammalian metabolic activation, and all such tests were repeated after an interval of at least 1 week.
Diallate and
triallate were tested in the Salmonella/microsome assay over dose ranges of 0.59 to 118.0 micrograms/plate and 6.37 to 1273 micrograms/plate, respectively. Both
diallate and
triallate gave positive results in S. typhimurium strains TA1535, TA98, and TA100 only in the presence of a rat-liver metabolic activation system. In Saccharomyces cerevisiae strain D7,
diallate was tested at concentrations from 1.18 to 29.50 micrograms/ml, and
triallate was tested at 0.955 to 9.548 micrograms/ml. Both
diallate and
triallate gave negative results for mitotic gene conversion, mitotic crossing-over, and reverse mutation. In the mouse
lymphoma L5178Y TK+/- assay,
diallate was tested at concentrations ranging from 1 to 72 micrograms/ml, and
triallate was tested at 0.5 to 60 micrograms/ml. Both
herbicides produced mutagenic responses in the mouse
lymphoma assay in the presence of metabolic activation. In the Drosophila sex-linked recessive lethal test, flies were exposed to 0.0004%
diallate and 0.001%
triallate. In this assay,
diallate was considered mutagenic, whereas
triallate did not produce a detectable mutagenic response.